A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight

NCT04447261 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BI 1356225
DRUG: Placebo

Sponsor

Boehringer Ingelheim